# Corcept Therapeutics Inc: Form 8-K, filed Sep 22, 2022

- Company: [Corcept Therapeutics Inc](/companies/cort.md) (CIK 1088856)
- Form: 8-K
- Filed: 2022-09-22
- Accepted by EDGAR: Sep 22, 2022, 16:33 ET
- Period: 2022-09-16
- Accession: 0001193125-22-249225
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1088856/000119312522249225/d325698d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1088856/000119312522249225/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1088856/000119312522249225/d325698d8k.htm

Filed Sep 22, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-249225. Last ingested by Listed: Nov 14, 2026, 21:12 ET. No prices; not investment advice.
